Aurum Care Management
Elevating Patient Support through Human-Centered Analytics

Aurum Care Management is redefining patient analytics in rare disease and oncology by humanizing data, combining compassionate care with strict regulatory standards. Instead of extracting numbers from claims or portals, Aurum builds its analytics on real patient conversations led by trained nurse counselors.

Each insight pairs self-reported experience with nurse observations, and then receives AI review under the supervision of preventive-medicine specialists and data consultants. The result is a dual-source, regulatory-grade dataset that measures outcomes, explains behavior, and exposes the barriers behind it.

That approach has translated into visible change that conventional Patient Support Program (PSP) datasets routinely miss. In a long-acting injection program, Aurum discovered that most discontinuations occurred after the first or second dose due to injection pain caused by technique differences across hospitals. Once shared with the sponsor, this insight triggered nationwide retraining, lifting treatment retention by more than 30 percentage points and earning a Global Top 3 Innovation Award.

In oncology, 73 percent of patients reported financial pressure that weakened adherence. This finding led to the launch of Orla Alternative Financing, which connects patients to public and private funding. The average out-of-pocket burden fell by 70 percent for patients on non-reimbursed oncology drugs, with some cases reaching 83 percent. Rare-disease patients gained access to high-cost therapies they would not otherwise be able to start.

Aurum’s analytics have also identified system-level gaps. In gene therapy coverage, reimbursement in Korea is limited to infants under 24 months, yet delayed referrals caused many eligible children to age out before diagnosis. Aurum’s data traced the delay to early routing to rehabilitation medicine rather than genetics or neurology. Presenting this finding to clinical societies fuels discussions about earlier screening, referral, and fairness in future reimbursement.

“Aurum’s analytics expose barriers hidden in systems, enable changes that improve clinical continuity, financial accessibility, and policy-level fairness,” says Bonggeun (Bon) Oh, founder and CEO.

Human AI Integration without Burdening Patients

Patients participate in a personalized PSP, facilitated by Orla Ring, in which they have 20-minute calls with nurse counselors during which they freely share their experiences, challenges, and daily routines. With consent, these conversations are structured in Orla Console, where AI helps detect shifts in adherence and emotional stressors to guide personalized interventions. It yields unusually authentic longitudinal insight as the data is generated as part of a meaningful interaction.

For elderly or cognitively burdened patients, Aurum built Orla Deviceless Patient Monitoring (DPM), a patented SMS-based solution requiring no app or data plan. Responses are interpreted by an AI back-end that tracks adherence and flags risk. This keeps insight continuous without excluding low-tech populations.

Compliance, Security, and Partner Trust

Aurum’s PSP and Patient Access Program (PAP) operate on a compliance-by-design framework aligned with MFDS, FDA, and global pharma QA standards. Every record is time-stamped, consent-linked, and validated; cross-checks for missing or duplicate entries run before reporting. Major global pharma partners audit Aurum regularly across integrity, pharmacovigilance, and privacy governance.

All data is encrypted end-to-end and stored in ISO 27001-certified environments. Patient information is handled in accordance with HIPAA, GDPR, and MFDS standards. The independent third-party assessor, KPMG, recently reviewed Aurum’s data management framework. Since its founding six years ago, the company has reported zero privacy or security incidents.

Aurum’s integrated platform, GetOrla, connects pharma and insurer systems to run PSPs and PAPs as ready-to-deploy frameworks or fully customized therapy-specific ecosystems. Partners value Aurum for reliable execution and its ability to blend empathy with evidence and turn lived patient experience into compliant, actionable, system-level insight that improves continuity, access, and fairness.

Aurum’s philosophy is that data should serve people. Behind every chart and metric is a patient, caregiver, or physician whose reality has been made more livable, fair, or hopeful, one life at a time.